TWINJECT Drug Patent Profile
Which patents cover Twinject, and what generic alternatives are available?
Twinject is a drug marketed by Impax and is included in one NDA.
The generic ingredient in TWINJECT is epinephrine. There is one drug master file entry for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Twinject
A generic version of TWINJECT was approved as epinephrine by BPI LABS on July 29th, 2014.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TWINJECT?
- What are the global sales for TWINJECT?
- What is Average Wholesale Price for TWINJECT?
Summary for TWINJECT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 9 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,115 |
| DailyMed Link: | TWINJECT at DailyMed |
Recent Clinical Trials for TWINJECT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Louisville | Phase 4 |
| Arthroplasty Foundation, Inc. | Phase 4 |
US Patents and Regulatory Information for TWINJECT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax | TWINJECT | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-002 | May 28, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Impax | TWINJECT | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-001 | May 30, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TWINJECT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Impax | TWINJECT | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-001 | May 30, 2003 | ⤷ Start Trial | ⤷ Start Trial |
| Impax | TWINJECT | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-002 | May 28, 2004 | ⤷ Start Trial | ⤷ Start Trial |
| Impax | TWINJECT | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-001 | May 30, 2003 | ⤷ Start Trial | ⤷ Start Trial |
| Impax | TWINJECT | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-002 | May 28, 2004 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TWINJECT
See the table below for patents covering TWINJECT around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Australia | 2005314174 | Method and apparatus for delivering epinephrine | ⤷ Start Trial |
| Australia | 2005314401 | Medicine injection devices and methods | ⤷ Start Trial |
| Brazil | PI0518415 | aparelho formando um dispositivo de injeÇço de medicamento, e, mÉtodos para acionar uma agulha de seringa atÉ uma profundidade de penetraÇço selecionada, e para injetar medicamento de uma seringa e armazenar a seringa apàs injeÇço do medicamento | ⤷ Start Trial |
| Brazil | PI0518460 | mÉtodo para tratar emergÊncia alÉrgica em um paciente, dispositivo de distribuiÇço de droga contendo uma soluÇço de epinefrina, e, kit para tratar uma emergÊncia alÉrgia' | ⤷ Start Trial |
| Canada | 2585707 | PROCEDE ET DISPOSITIF DE DELIVRANCE D'EPINEPHRINE (METHOD AND APPARATUS FOR DELIVERING EPINEPHRINE) | ⤷ Start Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for TWINJECT
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3678649 | LUC00378 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: COMBINAISON D'EPINEPHRINE ET DE DODECYLMALTOSIDE, SOUS TOUTES SES FORMES PROTEGEES PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/24/1846 20250211 |
| 3678649 | 2025C/508 | Belgium | ⤷ Start Trial | PRODUCT NAME: COMBINATIE VAN EPINEPHRINE EN DODECYLMALTOSIDE, IN ALLE VORMEN BESCHERMD DOOR HET BASISOCTROOI; AUTHORISATION NUMBER AND DATE: EU/1/24/1846 20240823 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch